FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081150 [Registered on: 21/02/2025] Trial Registered Prospectively
Last Modified On: 04/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Role of Homoeopathic Medicine in case of Anaemia 
Scientific Title of Study   Role of Homoeopathic Medicine in Anaemia using Boenninghausen Characteristics and Repertory by C M Boger- A Single Arm Prospective Clinical Study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIl  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mem Perme 
Designation  PGT Trainee 
Affiliation  National Institute of Homoeopathy 
Address  OPD No.10, Department of Repertory, National Institute of Homoeopathy, GE Block, Sector III, Salt Lake, Kolkata

North Twentyfour Parganas
WEST BENGAL
700106
India 
Phone  9402066837  
Fax    
Email  kamem25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Birendra Prasad Srivastava 
Designation  Professor 
Affiliation  National Institute of Homoeopathy 
Address  OPD No.10, Department of Repertory, National Institute of Homoeopathy, GE Block, Sector III, Salt Lake, Kolkata

North Twentyfour Parganas
WEST BENGAL
700106
India 
Phone  9432497634  
Fax    
Email  dr.srivastava61@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Birendra Prasad Srivastava 
Designation  Professor 
Affiliation  National Institute of Homoeopathy 
Address  OPD No.10, Department of Repertory, National Institute of Homoeopathy, GE Block, Sector III, Salt Lake, Kolkata

North Twentyfour Parganas
WEST BENGAL
700106
India 
Phone  9432497634  
Fax    
Email  dr.srivastava61@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Homoeopathy, GE Block, Sector III, Salt Lake, Kolkata West Bengal India, 700106 
 
Primary Sponsor  
Name  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy, GE Block, Sector III, Salt Lake, Kolkata West Bengal India 700106 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Mem Perme  National Institute Of Homoeopathy  OPD Room No.10, Department of Repertory, National Institute of Homoeopathy, GE Block, Sector III, Salt Lake, Kolkata 700106
North Twentyfour Parganas
WEST BENGAL 
09402066837

kamem25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Institute of Homeopathy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D649||Anemia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicine  1.Indicated individualized homoeopathic medicine will be prescribed, after a detailed or thorough case-taking in accordance with the directions laid down in the Organon of Medicine. 2.Repertorization of the cases will be done by considering the Totality of Symptoms using Boenninghausen Characteristics and Repertory by C M Boger. 3.Selection of Potency will be made depending on the individual case. 4.Repetition of doses and change of potency will be done according to the individualization of the case and following homoeopathic philosophy. 5.Hb % and Fatigue Severity Scale will be measured at baseline and after 6 - 7 months after treatment with the medicine. 6.Follow up will be done monthly till 6 months from the baseline.  
Comparator Agent  Not Applicable  Not Applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients suffering from anaemia, with hemoglobin level between 7g/dl -12g/dl

Patients of all socio-economic status and religions.

Patients willing to give consent to participating in the study.
 
 
ExclusionCriteria 
Details  Patients having Hemoglobin level less than 7gm/dl

Patients with early functional changes like any cause of trauma or injury due to which blood loss or low Hb% occur.

Patients with other diagnosed cases of anaemia viz. sickle cell anaemia, thalassemia, aplastic anaemia, hemolytic anaemia etc.

Patients suffering from chronic kidney disease, malignancy and heart disease etc.

patients who are on substance abuse or dependence.

Patients already taking homeopathic medicine for any chronic diseases.

Pregnant and lactating women.

Patients suffering from unstable mental or psychiatric illness or other uncontrolled or life-threatening illness.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Hb%  Baseline and 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Fatigue Severity Scale  Baseline and 6 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   22/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Anaemia is condition in which the number of red blood cell or the hemoglobin concentration within them is lower than the normal which cause easily Fatigue, shortness of breath, palpitation, vertigo, headache etc. if not treated can cause serious issue on health and development.
1. Sample will be selected following preliminary and detailed screening using selected criteria.
2. Inclusion and exclusion criteria will be strictly follow.
3. After consideration of drops-out cases a minimum 40 cases will be enrolled for the study.
4. Case-taking will be done as per the strict homoeopathic principle.
5. Baseline scoring will be taken using Hb% and FSS.
6. Analysis and evaluation of each cases will be done.
7. Miasmatic analysis will be done.
8. Repertorization will be done by using Boenninghausen Characteristic and Repertory.
9. Final selection of the remedy will be done after consultation with Materia Medica.
10. Potency, Doses and Repetition of the indicated remedies will be guided strictly as per homoeopathic principle.
11. General( non-medical) management including appropriate diet and regimen will be advised.
12. Subsequent prescription (follow-up) will be generated according to relevant homoeopathic principle and will be recorded in the follow-up sheet
13. The baseline data will be compared with the data obtained after  6th months.
14. the score obtained will be compared and the result will be analyzed as per statistical methods and interference will be done thereafter.

 
Close